IQVIA is trading 4% down at $237.95 as investors lock in gains following a significant 25% five-day advance triggered by its July 28 earnings beat and guidance raise.
- The move appears to be a period of consolidation after the stock's recent multi-day rally.
- Shares are facing additional pressure from broader weakness in the healthcare sector, even as major market indices trade higher.